Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer.

Choucair A, Pham TH, Omarjee S, Jacquemetton J, Kassem L, Trédan O, Rambaud J, Marangoni E, Corbo L, Treilleux I, Le Romancer M.

Oncogene. 2019 Jan 28. doi: 10.1038/s41388-019-0694-9. [Epub ahead of print]

PMID:
30692633
2.

LKB1 regulates PRMT5 activity in breast cancer.

Lattouf H, Kassem L, Jacquemetton J, Choucair A, Poulard C, Trédan O, Corbo L, Diab-Assaf M, Hussein N, Treilleux I, Le Romancer M.

Int J Cancer. 2019 Feb 1;144(3):595-606. doi: 10.1002/ijc.31909. Epub 2018 Oct 31.

PMID:
30289978
3.

Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation.

Zhao J, Zhang L, Mu X, Doebelin C, Nguyen W, Wallace C, Reay DP, McGowan SJ, Corbo L, Clemens PR, Wilson GM, Watkins SC, Solt LA, Cameron MD, Huard J, Niedernhofer LJ, Kamenecka TM, Robbins PD.

PLoS Biol. 2018 Jun 11;16(6):e2004663. doi: 10.1371/journal.pbio.2004663. eCollection 2018 Jun.

4.

Identification of HSP90 inhibitors as a novel class of senolytics.

Fuhrmann-Stroissnigg H, Ling YY, Zhao J, McGowan SJ, Zhu Y, Brooks RW, Grassi D, Gregg SQ, Stripay JL, Dorronsoro A, Corbo L, Tang P, Bukata C, Ring N, Giacca M, Li X, Tchkonia T, Kirkland JL, Niedernhofer LJ, Robbins PD.

Nat Commun. 2017 Sep 4;8(1):422. doi: 10.1038/s41467-017-00314-z.

5.

Alternative splicing of CNOT7 diversifies CCR4-NOT functions.

Chapat C, Chettab K, Simonet P, Wang P, De La Grange P, Le Romancer M, Corbo L.

Nucleic Acids Res. 2017 Aug 21;45(14):8508-8523. doi: 10.1093/nar/gkx506.

6.

Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit.

Pieralli F, Corbo L, Torrigiani A, Mannini D, Antonielli E, Mancini A, Corradi F, Arena F, Moggi Pignone A, Morettini A, Nozzoli C, Rossolini GM.

Intern Emerg Med. 2017 Aug;12(5):629-635. doi: 10.1007/s11739-017-1627-7. Epub 2017 Feb 4.

PMID:
28161884
7.

The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer.

Omarjee S, Jacquemetton J, Poulard C, Rochel N, Dejaegere A, Chebaro Y, Treilleux I, Marangoni E, Corbo L, Romancer ML.

Oncogene. 2017 May 4;36(18):2503-2514. doi: 10.1038/onc.2016.415. Epub 2016 Dec 12.

8.

Protein arginine methylation/demethylation and cancer.

Poulard C, Corbo L, Le Romancer M.

Oncotarget. 2016 Oct 11;7(41):67532-67550. doi: 10.18632/oncotarget.11376. Review.

9.

Inhibition of lipogenesis reduces inflammation and organ injury in sepsis.

Idrovo JP, Yang WL, Jacob A, Corbo L, Nicastro J, Coppa GF, Wang P.

J Surg Res. 2016 Jan;200(1):242-9. doi: 10.1016/j.jss.2015.06.059. Epub 2015 Jul 2.

10.

Role of JMJD6 in Breast Tumourigenesis.

Poulard C, Rambaud J, Lavergne E, Jacquemetton J, Renoir JM, Trédan O, Chabaud S, Treilleux I, Corbo L, Le Romancer M.

PLoS One. 2015 May 7;10(5):e0126181. doi: 10.1371/journal.pone.0126181. eCollection 2015.

11.

MFG-E8 inhibits neutrophil migration through αvβ₃-integrin-dependent MAP kinase activation.

Aziz M, Yang WL, Corbo LM, Chaung WW, Matsuo S, Wang P.

Int J Mol Med. 2015 Jul;36(1):18-28. doi: 10.3892/ijmm.2015.2196. Epub 2015 Apr 23.

12.

MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.

Vilquin P, Donini CF, Villedieu M, Grisard E, Corbo L, Bachelot T, Vendrell JA, Cohen PA.

Breast Cancer Res. 2015 Jan 30;17:13. doi: 10.1186/s13058-015-0515-1.

13.

WNT Agonist Decreases Tissue Damage and Improves Renal Function After Ischemia-Reperfusion.

Kuncewitch M, Yang WL, Corbo L, Khader A, Nicastro J, Coppa GF, Wang P.

Shock. 2015 Mar;43(3):268-75. doi: 10.1097/SHK.0000000000000293.

14.

Proximity ligation assay to detect and localize the interactions of ERα with PI3-K and Src in breast cancer cells and tumor samples.

Poulard C, Rambaud J, Le Romancer M, Corbo L.

Methods Mol Biol. 2014;1204:135-43. doi: 10.1007/978-1-4939-1346-6_12.

PMID:
25182767
15.

Novel roles of the CCR4-NOT complex.

Chapat C, Corbo L.

Wiley Interdiscip Rev RNA. 2014 Nov-Dec;5(6):883-901. doi: 10.1002/wrna.1254. Epub 2014 Jul 8.

PMID:
25044499
16.

A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers.

Nguyen NT, Vendrell JA, Poulard C, Győrffy B, Goddard-Léon S, Bièche I, Corbo L, Le Romancer M, Bachelot T, Treilleux I, Cohen PA.

Mol Oncol. 2014 Dec;8(8):1441-57. doi: 10.1016/j.molonc.2014.05.013. Epub 2014 Jun 10.

17.

LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.

Bouchekioua-Bouzaghou K, Poulard C, Rambaud J, Lavergne E, Hussein N, Billaud M, Bachelot T, Chabaud S, Mader S, Dayan G, Treilleux I, Corbo L, Le Romancer M.

Int J Cancer. 2014 Sep 15;135(6):1307-18. doi: 10.1002/ijc.28781. Epub 2014 Mar 4.

18.

JMJD6 regulates ERα methylation on arginine.

Poulard C, Rambaud J, Hussein N, Corbo L, Le Romancer M.

PLoS One. 2014 Feb 3;9(2):e87982. doi: 10.1371/journal.pone.0087982. eCollection 2014.

19.

Transcriptional repression of estrogen receptor α signaling by SENP2 in breast cancer cells.

Nait Achour T, Sentis S, Teyssier C, Philippat A, Lucas A, Corbo L, Cavaillès V, Jalaguier S.

Mol Endocrinol. 2014 Feb;28(2):183-96. doi: 10.1210/me.2013-1376. Epub 2013 Jan 1.

20.

A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis.

Etheridge SL, Cosgrove ME, Sangkhae V, Corbo LM, Roh ME, Seeliger MA, Chan EL, Hitchcock IS.

Blood. 2014 Feb 13;123(7):1059-68. doi: 10.1182/blood-2012-12-473777. Epub 2013 Dec 31.

21.

Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor.

Vilquin P, Villedieu M, Grisard E, Ben Larbi S, Ghayad SE, Heudel PE, Bachelot T, Corbo L, Treilleux I, Vendrell JA, Cohen PA.

Int J Cancer. 2013 Oct 1;133(7):1589-602. doi: 10.1002/ijc.28182. Epub 2013 May 2.

22.

hCAF1/CNOT7 regulates interferon signalling by targeting STAT1.

Chapat C, Kolytcheff C, Le Romancer M, Auboeuf D, De La Grange P, Chettab K, Sentis S, Corbo L.

EMBO J. 2013 Mar 6;32(5):688-700. doi: 10.1038/emboj.2013.11. Epub 2013 Feb 5.

23.

Activation of rapid oestrogen signalling in aggressive human breast cancers.

Poulard C, Treilleux I, Lavergne E, Bouchekioua-Bouzaghou K, Goddard-Léon S, Chabaud S, Trédan O, Corbo L, Le Romancer M.

EMBO Mol Med. 2012 Nov;4(11):1200-13. doi: 10.1002/emmm.201201615. Epub 2012 Oct 15.

24.

ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.

Vendrell JA, Thollet A, Nguyen NT, Ghayad SE, Vinot S, Bièche I, Grisard E, Josserand V, Coll JL, Roux P, Corbo L, Treilleux I, Rimokh R, Cohen PA.

Cancer Res. 2012 Jul 15;72(14):3593-606. doi: 10.1158/0008-5472.CAN-11-3095. Epub 2012 May 16.

25.

Cracking the estrogen receptor's posttranslational code in breast tumors.

Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir JM, Corbo L.

Endocr Rev. 2011 Oct;32(5):597-622. doi: 10.1210/er.2010-0016. Epub 2011 Jun 15. Review.

PMID:
21680538
26.

[Post-translational modifications modulate estrogen receptor alpha activity in breast tumors].

Poulard C, Bouchekioua-Bouzaghou K, Sentis S, Corbo L, Le Romancer M.

Med Sci (Paris). 2010 Jun-Jul;26(6-7):636-40. doi: 10.1051/medsci/2010266-7636. Review. French.

27.

Methylation, a key step for nongenomic estrogen signaling in breast tumors.

Le Romancer M, Treilleux I, Bouchekioua-Bouzaghou K, Sentis S, Corbo L.

Steroids. 2010 Aug-Sep;75(8-9):560-4. doi: 10.1016/j.steroids.2010.01.013. Epub 2010 Jan 29. Review.

PMID:
20116391
28.

Protein arginine methylation in estrogen signaling and estrogen-related cancers.

Teyssier C, Le Romancer M, Sentis S, Jalaguier S, Corbo L, Cavaillès V.

Trends Endocrinol Metab. 2010 Mar;21(3):181-9. doi: 10.1016/j.tem.2009.11.002. Epub 2009 Dec 11. Review.

29.

Regulation of estrogen rapid signaling through arginine methylation by PRMT1.

Le Romancer M, Treilleux I, Leconte N, Robin-Lespinasse Y, Sentis S, Bouchekioua-Bouzaghou K, Goddard S, Gobert-Gosse S, Corbo L.

Mol Cell. 2008 Jul 25;31(2):212-21. doi: 10.1016/j.molcel.2008.05.025.

30.

Identification of NF-kappaB responsive elements in follistatin related gene (FLRG) promoter.

Bartholin L, Guindon S, Martel S, Corbo L, Rimokh R.

Gene. 2007 May 15;393(1-2):153-62. Epub 2007 Mar 1.

PMID:
17395406
31.

hCAF1, a new regulator of PRMT1-dependent arginine methylation.

Robin-Lespinasse Y, Sentis S, Kolytcheff C, Rostan MC, Corbo L, Le Romancer M.

J Cell Sci. 2007 Feb 15;120(Pt 4):638-47. Epub 2007 Jan 30.

32.

Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.

Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L.

Mol Endocrinol. 2005 Nov;19(11):2671-84. Epub 2005 Jun 16.

PMID:
15961505
33.

Conservation of the deadenylase activity of proteins of the Caf1 family in human.

Bianchin C, Mauxion F, Sentis S, Séraphin B, Corbo L.

RNA. 2005 Apr;11(4):487-94.

34.

BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.

Morel AP, Sentis S, Bianchin C, Le Romancer M, Jonard L, Rostan MC, Rimokh R, Corbo L.

J Cell Sci. 2003 Jul 15;116(Pt 14):2929-36. Epub 2003 May 27.

35.

Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function.

Bartholin L, Maguer-Satta V, Hayette S, Martel S, Gadoux M, Corbo L, Magaud JP, Rimokh R.

Oncogene. 2002 Mar 28;21(14):2227-35.

37.

FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins.

Bartholin L, Maguer-Satta V, Hayette S, Martel S, Gadoux M, Bertrand S, Corbo L, Lamadon C, Morera AM, Magaud JP, Rimokh R.

Oncogene. 2001 Sep 6;20(39):5409-19.

38.
39.

AF15q14, a novel partner gene fused to the MLL gene in an acute myeloid leukaemia with a t(11;15)(q23;q14).

Hayette S, Tigaud I, Vanier A, Martel S, Corbo L, Charrin C, Beillard E, Deleage G, Magaud JP, Rimokh R.

Oncogene. 2000 Sep 7;19(38):4446-50.

40.

The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation.

Prévôt D, Voeltzel T, Birot AM, Morel AP, Rostan MC, Magaud JP, Corbo L.

J Biol Chem. 2000 Jan 7;275(1):147-53.

41.

Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex.

Rouault JP, Prévôt D, Berthet C, Birot AM, Billaud M, Magaud JP, Corbo L.

J Biol Chem. 1998 Aug 28;273(35):22563-9.

43.

The EBV early gene product EB2 transforms rodent cells through a signalling pathway involving c-Myc.

Corbo L, Le Roux F, Sergeant A.

Oncogene. 1994 Nov;9(11):3299-304.

PMID:
7936654
44.

Direct cloning of human transcripts with HnRNA from hybrid cell lines.

Corbo L, Maley JA, Nelson DL, Caskey CT.

Science. 1990 Aug 10;249(4969):652-5.

PMID:
2382140
45.

Inhibition by anti-HLA class I mAb of IL-2 and IL-2 receptor synthesis in lymphocytes stimulated with PHA-P.

De Felice M, Turco MC, Costanzo F, Corbo L, Ferrone S, Venuta S.

Cell Immunol. 1990 Apr 1;126(2):420-7.

PMID:
2311126
46.

Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources.

Nelson DL, Ledbetter SA, Corbo L, Victoria MF, Ramírez-Solis R, Webster TD, Ledbetter DH, Caskey CT.

Proc Natl Acad Sci U S A. 1989 Sep;86(17):6686-90.

47.

Oxygen consumption and guanosine diphosphate binding by fetal brown adipose tissue in diabetic pregnancy.

Neufeld ND, Corbo L, Stoddard A, Klein AH, Tadokoro N.

Metabolism. 1989 Sep;38(9):831-6.

PMID:
2549331
48.

Lack of a role of monocytes in the inhibition by monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens of PHA-P-induced peripheral blood mononuclear cell proliferation.

De Felice M, Turco MC, Corbo L, Carandente Giarrusso P, Lamberti A, Valerio G, Temponi M, Costanzo F, Ferrone S, Venuta S.

Cell Immunol. 1989 Aug;122(1):164-77.

PMID:
2473845
49.

Lymphocyte proliferative response to mitogenic monoclonal antibodies in systemic sclerosis. Evidence for unresponsiveness to murine monoclonal antibodies of IgG1 isotype.

Valentini G, Carandente Giarrusso P, Gualdieri L, Corbo L, Alfinito F, Turco MC, Venuta S, Giordano M.

Tissue Antigens. 1989 Apr;33(4):457-65.

PMID:
2734775
50.

Enhancing effect of anti-HLA class I monoclonal antibodies on T cell proliferation induced via CD2 molecule.

Turco MC, de Felice M, Corbo L, Giarrusso PC, Yang SY, Ferrone S, Venuta S.

J Immunol. 1988 Oct 1;141(7):2275-81.

PMID:
3262654

Supplemental Content

Support Center